private financing
Fore Biotherapeutics Raises $75M in Series D Funding
The firm will use the proceeds to advance its lead candidate, plixorafenib, in BRAF-mutant solid and central nervous system tumors.
Ambrx Biopharma Closes $75M Direct Offering
The firm will use the proceeds to further develop a drug for HER2-positive cancers and a treatment for PSMA-expressing tumors.
Immutep Raises $53M to Advance LAG-3 Immunotherapy Candidate
The funding will support ongoing late-stage trials of eftilagimod alpha in head and neck cancer and breast cancer.
Orchard Therapeutics Closes $34M Financing Round
Financing through the securities purchase agreement is contingent upon Orchard achieving US regulatory milestones for its lead candidate OTL-200.
ARTBio Launches With $23M Seed Funding to Develop Radiopharmaceuticals for Prostate Cancer
The firm will also use the funds to advance its AlphaDirect Pb212 isolation platform, with which it is hoping to overcome isotope production and distribution challenges.
Mar 1, 2023
2seventy Bio Prices $125M Public Offering
Jan 19, 2023
NeoPhore Raises $28.5M in Series B Financing
Nov 21, 2022